We aimed to investigate cartonectin levels in patients at predialysis and hemodialysis stages of chronic kidney disease in whom cartonectin levels had not been studied before and to observe various parameters that can affect cartonectin levels in these patients. This evidence concerns the gene C1QTNF3 and chronic kidney disease.